Loading...
XJPX
4403
Market cap3.64bUSD
Oct 09, Last price  
2,562.50JPY
1D
0.97%
1Q
-6.44%
Jan 2017
241.67%
Name

NOF Corp

Chart & performance

D1W1MN
XJPX:4403 chart
P/E
14.31
P/S
2.25
EPS
179.08
Div yield, %
1.97%
Shrs. gr., 5y
-1.60%
Rev. gr., 5y
8.36%
Revenues
257.97b
+8.25%
150,208,000,000159,045,000,000150,320,000,000143,384,000,000154,121,000,000152,364,000,000148,859,000,000160,963,000,000167,697,000,000170,460,000,000174,057,000,000179,935,000,000189,152,000,000180,917,000,000172,645,000,000192,642,000,000217,709,000,000222,252,000,000238,310,000,000257,967,000,000
Net income
40.55b
+11.10%
7,227,000,0006,559,000,0002,382,000,0003,500,000,0006,886,000,0007,319,000,0008,784,000,0009,737,000,00011,703,000,00013,589,000,00017,587,000,00019,912,000,00022,034,000,00021,140,000,00023,302,000,00026,691,000,00033,973,000,00033,991,000,00036,498,000,00040,551,000,000
CFO
35.87b
+23.78%
6,601,000,00011,793,000,000-386,000,00021,906,000,00014,299,000,00011,739,000,00013,025,000,00015,692,000,00014,230,000,00016,906,000,00024,024,000,00020,211,000,00019,864,000,00027,837,000,00030,726,000,00027,393,000,00023,333,000,00029,970,000,00028,975,000,00035,865,000,000
Dividend
Mar 30, 202735 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1937 and headquartered in Tokyo, Japan, NOF Corporation is a chemical manufacturing enterprise with diversified operations across several key sectors. The company primarily conducts business through its Functional Chemicals, Life Science, and Explosive & Propulsion divisions. The Functional Chemicals segment is responsible for producing a wide array of specialized substances, including fatty acids and their derivatives, various surfactants, ethylene oxide and propylene oxide derivatives, organic peroxides, advanced functional polymers and films, petrochemical products, electronic materials, and sophisticated corrosion prevention agents. Within its Life Science division, NOF offers products such as edible oils, nutritional supplements (functional foods), activated polyethylene glycol (PEG), unique functional lipids, pharmaceutical-grade surfactants, biocompatible materials, ingredients derived from plants, and MPC polymer/monomer. The Explosive & Propulsion segment focuses on manufacturing industrial explosives, solid and liquid propellants for firearms and rockets, pyrotechnic devices, complete guided missile assemblies, anti-freezing compounds, and specialized indicators for temperature and sterilization. Beyond its core chemical activities, the corporation also extends its business ventures into logistics, operates an insurance agency, and is involved in real estate.

Key people

Takeo Miyaji
Chairman of the Board, Chairman of the Executive Board, Representative Director · since 2023
Naoya Umehara
Managing Executive Officer, Chief Financial Officer · since 2024
Eui Kang
Managing Executive Officer, Chief Director of Research · since 2023
Kazuhito Narumi
Managing Executive Officer, Director of Chemicals Business · since 2023
Kenshiro Shuto
Managing Executive Officer, Director of Functional Materials Business · since 2023
Junko Hamamoto
Executive Officer, Director of Corporate Communications · since 2025
Yoshitaka Honda
Executive Officer, Director of Operation in Kawasaki Business Center, Manager of Kawasaki Business Center, Manager of Chidori Plant · since 2024
Tsuyoshi Izumisawa
Executive Officer, Director of Accounting · since 2024
Hiroyuki Kajikawa
Executive Officer, Director of Legal Affairs · since 2024
Satoshi Kataoka
Executive Officer, Director of Materials · since 2023
Hirofumi Kato
Executive Officer, Director of Functional Food Business · since 2023
Akihisa Maeda
Executive Officer, Director of Human Resource and General Affairs · since 2023
Toshiaki Sakaino
Executive Officer, Director of Business Planning · since 2024
Motoji Takimizu
Executive Officer, Director of Information System · since 2023
Kuniaki Tsuruoka
Executive Officer, Manager of Rust Prevention · since 2021
Yuji Yamamoto
Executive Officer, Chief Director of Sales, Director of Life Science Business · since 2025
Masanobu Miyo
Director · since 2023
Manabu Saito
Managing Executive Officer, Chief Compliance Officer, Director · since 2024
Koji Sawamura
President, Executive President, Chief Executive Officer, Representative Director · since 2023
Kazuyoshi Yamauchi
Managing Executive Officer, Chief Safety and Quality Officer, Chief Director of Technology, Director · since 2024
IPO date
Sep 01, 1949
Employees
3,818
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT